International registry of factor XIII dediciency

A Basis formed mostly on European data

Vytautas Ivaskevicius, Rainer Seitz, Hans P. Kohler, Verena Schroeder, L. Muszbek, Robert A S Ariens, Erhard Seifried, Johannes Oldenburg

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

FXIII deficiency is known as one of the rarest blood coagulation disorders. In this study, the phenotypic and in part genotypic data of 104 FXIII-deficient patients recorded from 1993-2005 are presented.The most common bleeding symptoms were subcutaneous bleeding (57%) followed by delayed umbilical cord bleeding (56%), muscle hematoma (49%), hemorrhage after surgery (40%), hemarthrosis (36%), and intracerebral bleeding (34%). Prophylactic treatment was initiated in about 70% of all patients. FXIII-B subunit-deficient patients had a milder phenotype than patients with FXIII-A subunit deficiency.The most frequent mutation affecting the F13A gene was a splice site mutation in intron 5 (IVS5-1 G>A).This mutation was found in eight (17%) of 46 analyzed families.The haplotype analysis of patients carrying the IVS5-1 A allele was consistent with a founder effect. The international registry (http://www.f13-database.de) will provide clinicians and scientists working on FXIII deficiency with a helpful tool to improve patient care and direct future studies towards better understanding and treatment of the disease.

Original languageEnglish
Pages (from-to)914-921
Number of pages8
JournalThrombosis and Haemostasis
Volume97
Issue number6
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Factor XIII
Registries
Hemorrhage
Mutation
Blood Coagulation Disorders
Hemarthrosis
Founder Effect
Umbilical Cord
Hematoma
Introns
Haplotypes
Patient Care
Alleles
Phenotype
Muscles
Therapeutics
Genes

Keywords

  • FXIII deficiency
  • Genotyping
  • International FXIII registry
  • Phenotyping

ASJC Scopus subject areas

  • Hematology

Cite this

Ivaskevicius, V., Seitz, R., Kohler, H. P., Schroeder, V., Muszbek, L., Ariens, R. A. S., ... Oldenburg, J. (2007). International registry of factor XIII dediciency: A Basis formed mostly on European data. Thrombosis and Haemostasis, 97(6), 914-921. https://doi.org/10.1160/TH07-01-0034

International registry of factor XIII dediciency : A Basis formed mostly on European data. / Ivaskevicius, Vytautas; Seitz, Rainer; Kohler, Hans P.; Schroeder, Verena; Muszbek, L.; Ariens, Robert A S; Seifried, Erhard; Oldenburg, Johannes.

In: Thrombosis and Haemostasis, Vol. 97, No. 6, 06.2007, p. 914-921.

Research output: Contribution to journalArticle

Ivaskevicius, V, Seitz, R, Kohler, HP, Schroeder, V, Muszbek, L, Ariens, RAS, Seifried, E & Oldenburg, J 2007, 'International registry of factor XIII dediciency: A Basis formed mostly on European data', Thrombosis and Haemostasis, vol. 97, no. 6, pp. 914-921. https://doi.org/10.1160/TH07-01-0034
Ivaskevicius, Vytautas ; Seitz, Rainer ; Kohler, Hans P. ; Schroeder, Verena ; Muszbek, L. ; Ariens, Robert A S ; Seifried, Erhard ; Oldenburg, Johannes. / International registry of factor XIII dediciency : A Basis formed mostly on European data. In: Thrombosis and Haemostasis. 2007 ; Vol. 97, No. 6. pp. 914-921.
@article{85ebdbd53f8c4e309e9bb750aba22155,
title = "International registry of factor XIII dediciency: A Basis formed mostly on European data",
abstract = "FXIII deficiency is known as one of the rarest blood coagulation disorders. In this study, the phenotypic and in part genotypic data of 104 FXIII-deficient patients recorded from 1993-2005 are presented.The most common bleeding symptoms were subcutaneous bleeding (57{\%}) followed by delayed umbilical cord bleeding (56{\%}), muscle hematoma (49{\%}), hemorrhage after surgery (40{\%}), hemarthrosis (36{\%}), and intracerebral bleeding (34{\%}). Prophylactic treatment was initiated in about 70{\%} of all patients. FXIII-B subunit-deficient patients had a milder phenotype than patients with FXIII-A subunit deficiency.The most frequent mutation affecting the F13A gene was a splice site mutation in intron 5 (IVS5-1 G>A).This mutation was found in eight (17{\%}) of 46 analyzed families.The haplotype analysis of patients carrying the IVS5-1 A allele was consistent with a founder effect. The international registry (http://www.f13-database.de) will provide clinicians and scientists working on FXIII deficiency with a helpful tool to improve patient care and direct future studies towards better understanding and treatment of the disease.",
keywords = "FXIII deficiency, Genotyping, International FXIII registry, Phenotyping",
author = "Vytautas Ivaskevicius and Rainer Seitz and Kohler, {Hans P.} and Verena Schroeder and L. Muszbek and Ariens, {Robert A S} and Erhard Seifried and Johannes Oldenburg",
year = "2007",
month = "6",
doi = "10.1160/TH07-01-0034",
language = "English",
volume = "97",
pages = "914--921",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "6",

}

TY - JOUR

T1 - International registry of factor XIII dediciency

T2 - A Basis formed mostly on European data

AU - Ivaskevicius, Vytautas

AU - Seitz, Rainer

AU - Kohler, Hans P.

AU - Schroeder, Verena

AU - Muszbek, L.

AU - Ariens, Robert A S

AU - Seifried, Erhard

AU - Oldenburg, Johannes

PY - 2007/6

Y1 - 2007/6

N2 - FXIII deficiency is known as one of the rarest blood coagulation disorders. In this study, the phenotypic and in part genotypic data of 104 FXIII-deficient patients recorded from 1993-2005 are presented.The most common bleeding symptoms were subcutaneous bleeding (57%) followed by delayed umbilical cord bleeding (56%), muscle hematoma (49%), hemorrhage after surgery (40%), hemarthrosis (36%), and intracerebral bleeding (34%). Prophylactic treatment was initiated in about 70% of all patients. FXIII-B subunit-deficient patients had a milder phenotype than patients with FXIII-A subunit deficiency.The most frequent mutation affecting the F13A gene was a splice site mutation in intron 5 (IVS5-1 G>A).This mutation was found in eight (17%) of 46 analyzed families.The haplotype analysis of patients carrying the IVS5-1 A allele was consistent with a founder effect. The international registry (http://www.f13-database.de) will provide clinicians and scientists working on FXIII deficiency with a helpful tool to improve patient care and direct future studies towards better understanding and treatment of the disease.

AB - FXIII deficiency is known as one of the rarest blood coagulation disorders. In this study, the phenotypic and in part genotypic data of 104 FXIII-deficient patients recorded from 1993-2005 are presented.The most common bleeding symptoms were subcutaneous bleeding (57%) followed by delayed umbilical cord bleeding (56%), muscle hematoma (49%), hemorrhage after surgery (40%), hemarthrosis (36%), and intracerebral bleeding (34%). Prophylactic treatment was initiated in about 70% of all patients. FXIII-B subunit-deficient patients had a milder phenotype than patients with FXIII-A subunit deficiency.The most frequent mutation affecting the F13A gene was a splice site mutation in intron 5 (IVS5-1 G>A).This mutation was found in eight (17%) of 46 analyzed families.The haplotype analysis of patients carrying the IVS5-1 A allele was consistent with a founder effect. The international registry (http://www.f13-database.de) will provide clinicians and scientists working on FXIII deficiency with a helpful tool to improve patient care and direct future studies towards better understanding and treatment of the disease.

KW - FXIII deficiency

KW - Genotyping

KW - International FXIII registry

KW - Phenotyping

UR - http://www.scopus.com/inward/record.url?scp=34250758556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250758556&partnerID=8YFLogxK

U2 - 10.1160/TH07-01-0034

DO - 10.1160/TH07-01-0034

M3 - Article

VL - 97

SP - 914

EP - 921

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 6

ER -